ZA831089B - Ergot peptide alkaloids - Google Patents

Ergot peptide alkaloids

Info

Publication number
ZA831089B
ZA831089B ZA831089A ZA831089A ZA831089B ZA 831089 B ZA831089 B ZA 831089B ZA 831089 A ZA831089 A ZA 831089A ZA 831089 A ZA831089 A ZA 831089A ZA 831089 B ZA831089 B ZA 831089B
Authority
ZA
South Africa
Prior art keywords
peptide alkaloids
ergot peptide
ergot
alkaloids
peptide
Prior art date
Application number
ZA831089A
Other languages
English (en)
Inventor
Georg Bollinger
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA831089B publication Critical patent/ZA831089B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA831089A 1982-02-17 1983-02-17 Ergot peptide alkaloids ZA831089B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH98782 1982-02-17

Publications (1)

Publication Number Publication Date
ZA831089B true ZA831089B (en) 1984-09-26

Family

ID=4199836

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA831089A ZA831089B (en) 1982-02-17 1983-02-17 Ergot peptide alkaloids

Country Status (19)

Country Link
JP (1) JPS58152884A (cs)
AU (1) AU1142083A (cs)
BE (1) BE895898A (cs)
CS (1) CS236786B2 (cs)
DD (1) DD209458A5 (cs)
DE (1) DE3304361A1 (cs)
DK (1) DK66483A (cs)
ES (1) ES519811A0 (cs)
FI (1) FI830462L (cs)
FR (1) FR2521562B1 (cs)
GB (1) GB2115811B (cs)
GR (1) GR79562B (cs)
IT (1) IT1197578B (cs)
NL (1) NL8300558A (cs)
NO (1) NO830482L (cs)
PL (1) PL240608A1 (cs)
PT (1) PT76242B (cs)
SE (1) SE8300865L (cs)
ZA (1) ZA831089B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734501A (en) * 1985-10-01 1988-03-29 Eli Lilly And Company N-alkylation of dihydrolysergic acid
GB0808326D0 (en) * 2008-05-08 2008-06-18 E Therapeutics Plc Compositions and methods for the treatment of fybromyalgia

Also Published As

Publication number Publication date
DK66483D0 (da) 1983-02-15
GB2115811B (en) 1985-08-14
FI830462A7 (fi) 1983-08-18
SE8300865D0 (sv) 1983-02-16
PT76242B (en) 1986-01-10
PT76242A (en) 1983-03-01
FR2521562A1 (fr) 1983-08-19
ES8407060A1 (es) 1984-08-16
FR2521562B1 (fr) 1985-10-25
NL8300558A (nl) 1983-09-16
SE8300865L (sv) 1983-08-18
BE895898A (fr) 1983-08-16
IT8347734A0 (it) 1983-02-17
GB2115811A (en) 1983-09-14
GB8304011D0 (en) 1983-03-16
NO830482L (no) 1983-08-18
DE3304361A1 (de) 1983-08-25
PL240608A1 (en) 1984-10-08
IT1197578B (it) 1988-12-06
FI830462L (fi) 1983-08-18
CS236786B2 (en) 1985-05-15
DD209458A5 (de) 1984-05-09
AU1142083A (en) 1983-08-25
FI830462A0 (fi) 1983-02-10
JPS58152884A (ja) 1983-09-10
ES519811A0 (es) 1984-08-16
DK66483A (da) 1983-08-18
GR79562B (cs) 1984-10-30

Similar Documents

Publication Publication Date Title
GB8315003D0 (en) Teichomycin
AU558414B2 (en) Ergot peptide
PH21382A (en) A-21978c cyclic peptide derivative
GB2120257B (en) Cyclic peptide derivatives
GB8310843D0 (en) Ergoline derivatives
GB2125041B (en) Ergot alkaloids
AU553514B2 (en) Vinca alkaloids
PH21234A (en) Ergot alkaloids
GB8304011D0 (en) Ergot peptide alkaloids
NZ189422A (en) Ergot peptide alkaloids
GB2152506B (en) Vinca alkaloids
GB2121030B (en) Ergot peptide derivatives
GB2092570B (en) Ergot alkaloids
ZA83955B (en) Ergot alkaloids
IE802091L (en) Ergot peptide alkaloids
GB2094798B (en) Ergot alkaloids
GB2131674B (en) Ashtray
GB8319929D0 (en) Amino derivatives
KR840000329Y1 (en) Ashtray
KR860000957Y1 (en) Ashtray
YU166182A (en) Spark detector
KR830001175Y1 (en) Ash-tray
AR241943A1 (es) Un procedimiento para la preparacion de un peptido ciclico a-21978c y sus sales
GB2126704B (en) Igniters
CS27182A1 (en) Parak bulcovin